Molecular Screening Services

A Tender Notice
by NHS BLOOD AND TRANSPLANT

Source
Find a Tender
Type
Contract (Services)
Duration
10 year
Value
£10M
Sector
HEALTH
Published
12 Jun 2023
Delivery
To 08 Jun 2033 (est.)
Deadline
31 Jul 2023 16:00

Concepts

Location

Bristol: Colindale

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a Managed Service provider to provide a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can detect HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA in EDTA plasma from blood and non-blood (e.g. stem cell, tissue) donors including from deceased (non-heart beating) donors.

Total Quantity or Scope

This is separate to any tender opportunity. Its purpose is to inform the market of the Molecular Screening tender opportunity. NHSBT are looking for a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can detect HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA in EDTA plasma from blood and non-blood (e.g. stem cell, tissue) donors including from deceased (non-heart beating) donors. The solution must have the relevant CE/UKCA marking to support this ability and be currently taking part in KEG to gain approval or already have approval from KEG to undertake this service.

Renewal Options

Up to a maximum of 5 years

CPV Codes

  • 71900000 - Laboratory services
  • 33000000 - Medical equipments, pharmaceuticals and personal care products
  • 33696500 - Laboratory reagents
  • 33696200 - Blood-testing reagents
  • 48921000 - Automation system
  • 33141625 - Diagnostic kits
  • 33124110 - Diagnostic systems
  • 33140000 - Medical consumables
  • 33124000 - Diagnostics and radiodiagnostic devices and supplies
  • 33127000 - Immuno-analysis devices

Indicators

  • This is a recurring contract.
  • Renewals are available.

Other Information

The solution must have the relevant CE/UKCA marking to support this ability.Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver Molecular Screening in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk ** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains